Results 71 to 80 of about 428 (116)

The Impact of Minimal Sunlight Exposure on Bone Health: Insights From a Cohort Study in Erythropoietic Protoporphyria.

J Clin Endocrinol Metab
Kluijver LG, Wagenmakers MAEM, Wilson JHP, Langendonk JG.   +3 more
europepmc   +1 more source

Emerging Therapeutic Innovations for Vitiligo Treatment. [PDF]

Curr Issues Mol Biol
Li W, Dong P, Zhang G, Hu J, Yang S.
europepmc   +1 more source

Up-and-Coming Drugs for the Treatment of Vitiligo. [PDF]

Ann Dermatol
Seong SH, Oh SH.
europepmc   +1 more source

Faculty Opinions recommendation of Afamelanotide for erythropoietic protoporphyria.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature, 2017
openaire   +2 more sources

Quality of life in children with erythropoietic protoporphyria: a case-control study. [PDF]

J Dermatol
Kluijver LG, Wensink D, Wagenmakers MAEM, Huidekoper HH, Witters P, Rymen D, Langendonk JG.   +6 more
europepmc   +1 more source

A systematic review of case series and clinical trials investigating systemic oral or injectable therapies for the treatment of vitiligo. [PDF]

Skin Res Technol
Jafarzadeh A, Pour Mohammad A, Khosravi M, Amiri S, Rasouli A, Keramati H, Goodarzi A.   +6 more
europepmc   +1 more source

Recent Advances in Vitiligo Treatment. [PDF]

Immunotargets Ther
Qiu Y, Su X, Chen J, Jiang S, Tang X, He Y, Liu F.   +6 more
europepmc   +1 more source

Inhibition of ABCG2 prevents phototoxicity in a mouse model of erythropoietic protoporphyria. [PDF]

Nat Commun
Zhu J, Qin FY, Lei S, Gu R, Qi Q, Lu J, Anderson KE, Wipf P, Ma X.   +8 more
europepmc   +1 more source

Seen on screen, missed in clinic: educational pearls from <i>House M.D.</i> - a reflective educational article on fictional cases in dermatology. [PDF]

Skin Health Dis
Shanshal M.
europepmc   +1 more source

Vitiligo: From Pathogenesis to Treatment. [PDF]

J Clin Med
Speeckaert R, Caelenberg EV, Belpaire A, Speeckaert MM, Geel NV.   +4 more
europepmc   +1 more source